| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0037-1963(01)90113-1 |
| P698 | PubMed publication ID | 11526597 |
| P2093 | author name string | Sawyers CL | |
| P2860 | cites work | Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia | Q29547900 |
| Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification | Q29618788 | ||
| Signal transduction pathways involved in BCR-ABL transformation | Q30176519 | ||
| Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome | Q33336718 | ||
| Chronic myeloid leukemia | Q33603077 | ||
| The biology of chronic myeloid leukemia | Q33686190 | ||
| Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571 | Q73088370 | ||
| P433 | issue | 3 Suppl 8 | |
| P921 | main subject | leukemia | Q29496 |
| chronic myeloid leukemia | Q729735 | ||
| P304 | page(s) | 15-21 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Seminars in Hematology | Q15765535 |
| P1476 | title | Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors | |
| P478 | volume | 38 |
| Q28215884 | Bcr-Abl is a "molecular switch" for the decision for growth and differentiation in hematopoietic stem cells |
| Q44427680 | Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity |
| Q33584244 | K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate |
| Q35790781 | Molecular biological design of novel antineoplastic therapies |
| Q44443441 | Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR. |
| Q35022540 | The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model |
Search more.